A new Cochrane review showed SSRIs and SNRIs outperform placebo for GAD with similar dropout rates, but questions remain ...

Shares in Mind Medicine (MNMD) are surging, following a shift in market sentiment regarding possible growth and the potential ...

“Hyperthyroidism is often linked to Graves’ disease, another autoimmune condition that overstimulates the thyroid. Thyroid ...

A new review from the Cochrane Database of Systematic Reviews confirms that antidepressants can effectively reduce symptoms ...

Virtual reality meditation effectively reduces depression and anxiety symptoms while improving emotional regulation in ...

AI-driven tools harness ML algorithms to provide insights into anxiety disorders. Supervised ML models, such as logistic ...

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.

Mind Medicine (MNMD) announced that the first patient has been dosed in Panorama, its second Phase 3 study evaluating MM120 ...

I grew up in Austintown and Madison grew up in Canfield.” In December last year, the two psychiatric nurse practitioners ...

In people with treatment-resistant depression, investigational inhalable mebufotenin yielded a 15.5-point placebo-adjusted ...